Abstract Details
|
Rahul Remanan, MBBS
(Nanoveda)
PRESENTER |
No disclosure on file |
| Kevin N. Sheth, MD, FAAN (Yale UniversityDivision of Neuro and Critical Care) | Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care. |
| No disclosure on file | |
| Vahid Tohidi, MD, PhD | Dr. Tohidi has nothing to disclose. |
| Lindsay J. Kaplan | No disclosure on file |
| No disclosure on file | |
| Mona Shahbazi (Hospital for Special Surgery) | No disclosure on file |
| Dale J. Lange, MD, FAAN (Lange Neurology, PC) | No disclosure on file |